C0206035||Randomized Controlled Noninferiority Trial
C0004096||Asthma
C1696465||placebo
C0542339||inferior
C0581124||mild
C0581125||moderate
C0349790||asthma exacerbations
C1706712||additional treatment
C3266628||persistent
C0004096||asthma
C0034656||randomized
C1696465||placebo
C0178941||follow-up telephone interview
C0011777||dexamethasone
C0032952||prednisone
C0178941||telephone follow-up
C0011777||dexamethasone
C0019993||hospitalization
C1512346||visit
C0011777||dexamethasone
C0032952||prednisone
C0032952||prednisone
C0581124||mild
C0581125||moderate
C0349790||asthma exacerbations
C3714738||compliance
C0011777||dexamethasone